News

Affymetrix executive vice president, general counsel and secretary Rick Runkel said they are pleased that the Federal Circuit has affirmed the District Court’s prior rulings that Affymetrix does

The company has posted a net income of $3.35m for the second quarter of 2011, compared to $ 4.14m for the same period in 2010. For the six

The Phase I trial conducted in healthy volunteers and a Phase IIa clinical trial in stable heart failure patients met the safety, tolerability, pharmacokinetics and pharmacodynamic effects of

Onsolis, which will be marketed as Breakyl, is indicated for the management of pain in opioid tolerant, adult patients with cancer. BDSI’s Onsolis is expected to be marketed

With this acquisition, Frutarom will strengthen its activity and market share in developing markets in Eastern Europe, Africa and Asia, and will strengthen its current product supply chain

As per the terms of the deal, Autifony will issue 850,000 A ordinary shares to GSK in exchange for a number of pre-candidate voltage-gated ion channel modulator compounds

The agreement replaces a promotion agreement that the companies signed in July 2008. The tie up allows Santarus to record revenue from Glumetza sales in the US effective

The grant is expected to fund two thirds of the development cost of the project. Within this subsidized project, Activus will develop ophthalmic solutions that would differ from

Moviprep is a laxative solution that increases the amount of water in the intestinal tract to stimulate bowel movements. This medication also contains potassium, sodium and other minerals